Patent · US Active

NK3 modulators and uses thereof

US12281114B2 · kind B2 · utility

0Cited by
3References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 12, 2024
Grant dateApr 22, 2025
Priority date
Expiry dateAug 12, 2044

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to compounds useful as modulators of neurokinin receptor 3 (NK3) for the treatment of conditions or disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.